To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Condoliase Improves Quality of Life in Lumbar Disc Herniation

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
September 2025

Condoliase Improves Quality of Life in Lumbar Disc Herniation

Vol: 307| Issue: 9| Number:14| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Impact of Condoliase on Health-related Quality of Life in Participants With Radicular Leg Pain Associated With Lumbar Disk Herniation: Results From a United States Phase 3 Clinical Trial.

Spine (Phila Pa 1976) . 2025 Jun 15;50(12):796-803.

Contributing Authors:
KE Macadaeg KD Kim PB Gupta J Rivera A Patel K Chauhan J Watanabe T Seo E Zucker K Candido

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Three hundred forty-one randomized patients with Lumbar Disk Herniation (LDH) -associated unilateral radicular leg pain were analyzed (modified ITT): condoliase (n=169) vs sham (n=172). The primary outcomes for this exploratory report were HRQoL changes (EQ-5D-5L domains and EQ-VAS) at weeks 13 and 52. Secondary outcomes included SF-36 PCS/MCS, PGIC and CGIC responder proportions, and WPAI domains...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue